DEC 23, 2018 10:51 PM PST

Super-Drug for Pediatric Leukemia?

WRITTEN BY: Nouran Amin

In a final study published in Genes & Development, researchers at Northwestern University School of Medicine concluded their discoveries on two successful therapeutics that were seen to slow the progression of pediatric leukemia in model mice through the targeting of a key protein called MLL. "This opens up a new therapeutic approach not only for leukemia, which is so important for the many children who are diagnosed with this terrible cancer, but also for other types of cancers that plague the population," says first author and postdoctoral research fellow, Zibo Zhao.

Learn more about pediatric leukemia:

The mortality rate of childhood leukemia, a cancer affecting the blood and bone marrow, is very high with just a 30 percent survival rate. The study focused primarily on two of the most commonly found leukemia’s in children: acute myeloid leukemia (AML) and acute lymphocytic leukemia (ALL).

Credit: The Dana Farber Cancer Institute

"These white blood cells infiltrate many of the tissues and organs of the affected individuals and is a major cause of death in leukemia patients," says senior author of the study, Ali Shilatifard. "This is a monster cancer that we've been dealing with for many years in children."

The study identified the MLL stabilization process that therapeutically treats the cancer. Researchers are now hoping to combine these successful therapeutics for the ultimate ‘super-drug’ in targeting MLL effectively and decreasing the mortality rate among children diagnosed with pediatric leukemia. "I've been working on this translocation for more than two decades, and we're finally at the point where in five to 10 years, we can get a drug in kids that can be effective," Shilatifard said. "If we can bring that survival rate up to 85 percent, that's a major accomplishment."

Source: Genes & Development, Northwestern University

About the Author
  • Nouran earned her BS and MS in Biology at IUPUI and currently shares her love of science by teaching. She enjoys writing on various topics as well including science & medicine, global health, and conservation biology. She hopes through her writing she can make science more engaging and communicable to the general public.
You May Also Like
JAN 06, 2020
Drug Discovery & Development
JAN 06, 2020
Designing Drugs To Fight off C. Diff Infections
A study published by PNAS explains breakthrough research around designing drugs that target C. diff bacterial infections that result in 15,000 deaths in th...
JAN 16, 2020
Health & Medicine
JAN 16, 2020
Babies in Africa Receive World's First Malaria Vaccine
Would you accept a vaccine that was only 40% effective? For those at risk of malaria, the answer is likely a resounding, "yes!" According to the...
JAN 15, 2020
Drug Discovery & Development
JAN 15, 2020
Acid-Reflux Drugs May Negatively Impact Breast Cancer Survivors
Many of us have taken some form of an acid-reflux drug—especially after a meal that causes discomfort. However, now researchers are indicating that s...
JAN 15, 2020
Drug Discovery & Development
JAN 15, 2020
A New Drug Target for Substance Abuse
Research carried out by the University of Minnesota Medical School indicates a new drug target for treating a drug addiction. Researchers note that the dru...
FEB 08, 2020
Drug Discovery & Development
FEB 08, 2020
Drug Targets Brain-Eating Amoebas
Brain-eating amoebas lead to high rates of mortality as a result of encephalitis. In fact, more than 95% of people who develop the infection will die. Unfo...
FEB 25, 2020
Drug Discovery & Development
FEB 25, 2020
FDA Approves Non-Statin Drug to Lower Cholesterol
The US Food and Drug Administration (FDA) has approved a new drug that lowers cholesterol levels.The drug, known as Nexletol, works differently from existi...
Loading Comments...